As the first qualified Third-grade Class-A Hospital in Jilin Province, The First Hospital of Jilin University has one national level key discipline and 17 national clinical key specialized discipline construction projects. This hospital has 4 experts of the “Thousand Talents Program” accredited by the Organization Department of the Central Committee of the CPC, 1 Cheung Kong Scholars Distinguished Professor, 1 Cheung Kong Scholars Chair Professor and 4 Changbai Mountain Scholars Distinguished Professors. In 2016, this hospital had diagnosed and treated 4.01 Million patients (person-time) through the outpatient services and emergency treatment services, and 240,000 patients had accepted hospitalized treatment and discharged from this hospital in 2016. At present, The First Hospital of Jilin University is keeping in step with the national strategy of deepening the medical and health system reform and seizing the historical opportunity of “Health China” strategy, actively exploring the new medical health service mode, and it is striving to build an international top large hospital group that integrates services of research type, creation type, operations type and service type.
As a large comprehensive enterprise group with the mixed ownership, Yatai Group was listed on the Shanghai Stock Exchange in 1995. With the main business covers building materials, real estate, finance, pharmaceuticals, and the penetration fields of coal, commerce & trade, sports culture and internet media, Yatai Group has ranked on the list of Top 500 Chinese Enterprises for many consecutive years, and it ranked No. 329 on that list in 2016. Facing with the new normal economy and various international and domestic challenges, Yatai Group is tightly focusing on the national “13th Five-Year” planning layout and endeavoring to seize the opportunity of “The Belt and Road” and the policy opportunity of “Northeast China Area Revitalization Plan” and relying on the big health industry development platform, so as to accelerate the promotion of constructing major projects such as the pharmaceutical industrial park as well as the internal industry M&A and reorganization, actively build the big health industry chain centered on “resources development, new drugs R&D, pharmaceutical production, pharmaceutical circulation, advanced medical equipment R&D and manufacturing, and health service”, continuously promote its core competitiveness, develop the health industry to become a new pillar industry, and create a new era for Yatai Group.